menu
    • menu

    Company profile for Almirall

    NEW Drugs in Dev: 27
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Almirall is a pharmaceutical company committed to providing valuable medicines to patients worldwide. We research, develop, manufacture and market proprietary medicines as well as licensed products, in areas with unmet medical needs. Today, our products are available in over 70 countries on five continents, through our 14 affiliates and a strategic partnership network.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AlmirallSpain_new Flag
    Country
    Country
    Spain
    Address
    Address
    Ronda General Mitre, 151 08022 Barcelona
    Telephone
    Telephone
    +34 93 291 30 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.almirall.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/almirall/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Almirall Sustains Q1 2026 Growth With 19.3% Yoy Surge
    Almirall Sustains Q1 2026 Growth With 19.3% Yoy Surge

    11 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-11/almirall-continues-its-positive-trajectory-in-q1-2026-in-line-with-expectations-led-by-193-yoy-g

    PHARMIWEB
    11 May 2026
    Share Share
    Evotec Picks First Preclinical Candidate in Almirall Derm Deal
    Evotec Picks First Preclinical Candidate in Almirall Derm Deal

    04 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-04/evotec-announces-nomination-of-first-preclinical-development-candidate-in-dermatology-collaboration

    PHARMIWEB
    04 May 2026
    Share Share
    Almirall, BSC Expand Collaboration to Boost Dermatology R&D
    Almirall, BSC Expand Collaboration to Boost Dermatology R&D

    13 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-13/almirall-and-barcelona-supercomputing-center-expand-their-collaboration-to-accelerate-innovation-in

    PHARMIWEB
    13 Apr 2026
    Share Share
    Lebrikizumab Shows 4-Year Control In Atopic Dermatitis
    Lebrikizumab Shows 4-Year Control In Atopic Dermatitis

    27 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260327314744/en/Lebrikizumab-delivered-long-term-disease-control-for-up-to-four-years-in-patients-with-moderate-to-severe-atopic-dermatitis

    BUSINESSWIRE
    27 Mar 2026
    Share Share
    Almirall 17th Skin Academy Highlights Advances In Skin Diseases
    Almirall 17th Skin Academy Highlights Advances In Skin Diseases

    23 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-23/almiralls-17th-skin-academy-highlights-scientific-advances-in-inflammatory-skin-diseases-and-skin-c

    PHARMIWEB
    23 Mar 2026
    Share Share
    Almirall Inaugurates Offices In China To Advance Innovation
    Almirall Inaugurates Offices In China To Advance Innovation

    12 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260312083794/en/Almirall-Inaugurates-Offices-in-China-to-Advance-Innovation-in-Medical-Dermatology-Through-Partnerships

    BUSSINESSWIRE
    12 Mar 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Almirall and get a quotation

    Almirall is a supplier offers 8 products (APIs, Excipients or Intermediates).

    Find Aclidinium Bromide bulk with DMF, JDMF offered by Almirall

    Find Ebastine bulk with CEP, JDMF offered by Almirall

    Find Aceclofenac bulk with CEP offered by Almirall

    Find Ebastine bulk with CEP offered by Almirall

    Find Almotriptan Malate bulk offered by Almirall

    Find LAS 34475 bulk offered by Almirall

    Find Almotriptan bulk offered by Almirall

    Find Ebastine bulk offered by Almirall

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search